CD274 and neoplasm: Although numerous studies have explored radiomics for non-invasively predicting the efficacy of immunotherapy [11,12], these studies were primarily based on traditional immune biomarkers, such as PD-L1, T-cell infiltration, tumor mutational burden, etc., and aimed to predict immunotherapy efficacy by establishing relationships between imaging characteristics and gene expression.